1. Carboranyl-Chlorin e6 as a Potent Antimicrobial Photosensitizer.
- Author
-
Omarova EO, Nazarov PA, Firsov AM, Strakhovskaya MG, Arkhipova AY, Moisenovich MM, Agapov II, Ol'shevskaya VA, Zaitsev AV, Kalinin VN, Kotova EA, and Antonenko YN
- Subjects
- Anti-Infective Agents chemistry, Bacterial Outer Membrane Proteins genetics, Bacterial Outer Membrane Proteins metabolism, Chlorophyllides, Escherichia coli metabolism, Escherichia coli Proteins genetics, Escherichia coli Proteins metabolism, Liposomes metabolism, Membrane Transport Proteins genetics, Membrane Transport Proteins metabolism, Photosensitizing Agents chemistry, Porphyrins chemistry, Spectrometry, Fluorescence, Anti-Infective Agents pharmacology, Cell Membrane metabolism, Gram-Negative Bacteria drug effects, Gram-Positive Bacteria drug effects, Photosensitizing Agents pharmacology, Porphyrins pharmacology
- Abstract
Antimicrobial photodynamic inactivation is currently being widely considered as alternative to antibiotic chemotherapy of infective diseases, attracting much attention to design of novel effective photosensitizers. Carboranyl-chlorin-e6 (the conjugate of chlorin e6 with carborane), applied here for the first time for antimicrobial photodynamic inactivation, appeared to be much stronger than chlorin e6 against Gram-positive bacteria, such as Bacillus subtilis, Staphyllococcus aureus and Mycobacterium sp. Confocal fluorescence spectroscopy and membrane leakage experiments indicated that bacteria cell death upon photodynamic treatment with carboranyl-chlorin-e6 is caused by loss of cell membrane integrity. The enhanced photobactericidal activity was attributed to the increased accumulation of the conjugate by bacterial cells, as evaluated both by centrifugation and fluorescence correlation spectroscopy. Gram-negative bacteria were rather resistant to antimicrobial photodynamic inactivation mediated by carboranyl-chlorin-e6. Unlike chlorin e6, the conjugate showed higher (compared to the wild-type strain) dark toxicity with Escherichia coli ΔtolC mutant, deficient in TolC-requiring multidrug efflux transporters.
- Published
- 2015
- Full Text
- View/download PDF